Prof. Omaima M Sabek, United States
Assessing the Potency of Autologous MSCs by correlating Serum IDO levels and regulatory T cell in Living-Donor Kidney Transplant Recipients
Dr. Megan Sykes, United States
The first report of three-way macrochimerism and alloreactivity using single cell profiling in a patient receiving multivisceral transplantation following loss of an initial liver-intestine transplant
Prof. Bruce M Hall, Australia
T regulatory cell phenotypes in renal transplant patients with long surviving graft, increased Th2-like Treg and reduced Th1- and Th17-like Treg
Dr. Ming Zheng, People's Republic of China
Rictor-mediated macrophage activation ameliorates antibody-mediated rejection of renal allografts by targeting p65 ubiquitination and NLRP3 transcription
Dr. Nirupama D Verma PhD, Australia
Human CD4+CD25+CD127lo Treg can be activated in vitro with alloantigen and rIL-4 to induce receptor for interleukin 5 (IL-5Ra)
Prof. Francesco D'Amico, Italy
N-acetylcysteine and liver transplant. Advantages of its administration in multi-organ donors especially during a world economical crisis. Long-term sub-group analysis in a randomized study
Dr. Jiale Wang, People's Republic of China
ISL1-overexpressing BMSCs attenuate renal ischemia-reperfusion injury by suppressing apoptosis and oxidative stress through the paracrine action
Dr. Takuya Harada, Japan
NLRP3 inhibition prevented graft infiltration of inflammatory macrophages leading to long-term graft acceptance in mouse heart transplantation